- Did you mean
- done-response
Search results - 27 results
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
cohort study of 65 kidney transplant recipients who received 3 doses of BNT162 b2 mRNA vaccine. Associations among breakthrough infection (BTI), vaccine responses, and patient characteristics were explored ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Service: Réponse immunitaire Immuunrespons Immune response Manuscript versions: DOI: ...
Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.
immunoglobulins (RIG) after exposure is still recommended regardless of prior vaccination, due to a lack of data. We aimed to assess the one-year boostability of a 3-dose rabies pre-exposure prophylaxis (PrEP) ...
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 antibodies among ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Marc; Peter A van Dam Source: Clin Cancer Res (2022) Abstract: PURPOSE: Cancer patients display reduced humoral responses after double-dose COVID-19 vaccination while their cellular response is more ...
Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD.
interaction. Among the dose ratios studied for both types of combination, a higher synergistic potential was highlighted for FOR / TIO 2:1 (). This was done through three steps by using multiple additions of ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
lower response to the vaccine such as anti- CD19, anti- CD20 or anti- CD38 therapies, low (naive) CD4 T-cell counts, genetic or therapeutic Bruton tyrosine kinase deficiency, treatment with ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Service: Réponse immunitaire Immuunrespons Immune response Manuscript versions: DOI: https://pubmed.ncbi.nlm.nih.gov/35172125/ Version: Published Full text language: English Category: A2 FOS ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron. Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
PATIENTS AND METHODS: In this interventional prospective multicohort study, priming and booster doses of the BNT162 b2 COVID-19 vaccine were administered 21 days apart to solid tumor patients receiving ...